| A conversation with Arthur Kavanaugh. | |
| | |
MedLine Citation:
|
PMID: 17849730 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Biologic therapies play a greater role in the treatment of human autoimmune diseases than they did in the past. Arthur Kavanaugh, MD, Professor of Clinical Medicine, University of California, San Diego, School of Medicine, talked with Managed Care Interface about the use of these agents, ongoing research in this area, and genetic factors that can come into play when treating rheumatoid arthritis. |
| | |
Authors:
|
Arthur Kavanaugh |
Publication Detail:
|
Type: Interview |
Journal Detail:
|
Title: Managed care interface Volume: 20 ISSN: 1096-5645 ISO Abbreviation: Manag Care Interface Publication Date: 2007 Jul |
Date Detail:
|
Created Date: 2007-09-13 Completed Date: 2007-10-16 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9715194 Medline TA: Manag Care Interface Country: United States |
Other Details:
|
Languages: eng Pagination: 26-7, 30 Citation Subset: H |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Autoimmune Diseases
/
drug therapy* Biological Therapy* Humans Treatment Outcome United States |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Current management of rheumatoid arthritis.
Next Document: Direct economic effect following mupirocin therapy failure among patients with uncomplicated skin an...